|

Mesothelioma Breakthrough Can Spare the Diaphragm

ByHolly Zink
Mesothelioma Breakthrough Can Spare the Diaphragm

A new study shows that surgery for malignant pleural mesothelioma can spare the diaphragm without reducing overall survival.

This study was conducted by medical researchers from St. Bartholomew’s Hospital in the United Kingdom.

Surgery for Malignant Pleural Mesothlioma

Mesothelioma is a type of cancer caused by exposure to asbestos. It can take decades after asbestos exposure for the cancer to develop. It is an aggressive cancer and can be hard to treat.

When the cancer grows in your lungs, it is called malignant pleural mesothelioma (MPM). Conventional treatment for MPM may include surgery, radiation therapy, and chemotherapy. Surgery is the most invasive treatment option and not every patient is eligible for surgery. If the patient is too ill or if the cancer has spread too much, surgery would be ineffective.

When doctors perform surgery to remove the mesothelioma tumors from the lungs, they try to preserve as much healthy lung tissue as possible. This procedure is called pleurectomy/decortication (PD). This can be difficult depending on how much the cancer has spread. If the doctor tries to spare healthy lung tissue by leaving some cancerous tissue behind, the patient may continue to suffer. But if the doctor removes too much lung tissue, the patient could also face serious side effects.

This aim of this study was to explore the effects of PD that spared the diaphragm in MPM patients. The hope was that leaving the diaphragm intact while removing cancerous tissue would not harm the patient.

Shorter Surgery, Shorter Hospital Stay

The study researchers looked at 136 patients undergoing surgery for MPM. Twenty-eight of those patients had surgery without removing any part of their diaphragm.

The patients in this group had shorter operations and shorter hospital stays than patients who tissue from their diaphragm removed. They also had shorter duration of “air leak”, which is when air from the lungs leaks into the chest cavity.

The study researchers recommend that the diaphragm should be spared whenever possible when surgically removing MPM from a patient’s lungs.

Source

Lee M, Ventura L, Baranowski R, Hargrave J, Waller D. The Effects of Preserving the Diaphragm on Early and Late Outcome of Lung-Sparing Radical Surgery for Malignant Pleural Mesothelioma. J Clin Med. 2022;11(22):6839. Published 2022 Nov 19. doi:10.3390/jcm11226839

Similar Posts

Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma
| |

Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

ByAlex Strauss

A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

Does Radiotherapy Reduce Mesothelioma Pain?
| |

Does Radiotherapy Reduce Mesothelioma Pain?

ByAlex Strauss

A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

Ape Virus Shrinks Mesothelioma Tumors in Lab
|

Ape Virus Shrinks Mesothelioma Tumors in Lab

ByAlex Strauss

A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

Repeat HIPEC Improves Mesothelioma Survival
| |

Repeat HIPEC Improves Mesothelioma Survival

ByAlex Strauss

If one cytoreductive surgery and HIPEC procedure for mesothelioma is good, subsequent treatments may be even better. That is the central message of research conducted at the Moffitt Cancer Center in Florida. The study’s aim was to assess overall survival among peritoneal mesothelioma patients who had not just one, but two or more rounds of heated intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery. The cytoreduction/HIPEC approach has become popular for peritoneal mesothelioma, a treatment-resistant cancer of abdominal membranes caused by asbestos. Cytoreductive surgery involves removing as much of the mesothelioma tumor as possible from the abdomen. Because the shape and spreading pattern of mesothelioma tumors make complete cytoreduction difficult, the surgery is often followed by a rinse with a heated solution…

Value of Mesothelioma Surgery Challenged for Healthy Patients
| |

Value of Mesothelioma Surgery Challenged for Healthy Patients

ByAlex Strauss

New research conducted in Italy and presented at the 15th World Conference on Lung Cancer in Sydney, Australia suggests that mesothelioma surgery – no matter what kind – may not offer a survival advantage over medical management for the healthiest of patients. Mesothelioma is a rare but aggressive malignancy that is highly resistant to standard cancer treatments. The two types of mesothelioma surgery considered to be options for people with resectable cancer are pleurectomy decortication (P/D) or extrapleural pneumonectomy (EPP). While EPP is more radical than P/D because it involves removing a lung, both carry a heavy risk of complications and, according to the Italian researchers, may not be of value for certain patients. The study reviewed data from 1,365…

Micro-RNAs May Offer New Way to Fight Mesothelioma
| |

Micro-RNAs May Offer New Way to Fight Mesothelioma

ByAlex Strauss

Scientists at one of the world’s top mesothelioma research centers, the Asbestos Diseases Research institute in Sydney, Australia, say that restoring the expression of certain micro RNAs in the cells of mesothelioma patients may offer a new way to fight the disease. A microRNA is a small RNA molecule which is involved in the regulation of gene expression. According to a new report in the Annals of Oncology, the Australian scientists found reduced expression of the micro RNA-15 family (miR-15/16) in the cells of mice with mesothelioma. “When malignant pleural mesothelioma cell lines were compared with the normal mesothelial cell line MeT-5A, the downregulation of miR-15/16 was 2- to 10-fold,” they report. This finding is consistent with previous cancer research…